The HCPLive peptic ulcer page is a resource for medical news and expert insights on stomach ulcers. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for peptic ulcer, and more.
January 20th 2017
China's type 2 diabetes mellitus (T2DM) epidemic continues to be a pervasive, costly health care issue, with proportions surpassed only by epidemic here in the US. The majority of T2DM treatment guidelines recommend metformin as the first-line anti-hyperglycemic agent for diabetes management due to its relative safety, tolerability, and cost-effectiveness.
A recent meta-analysis indicates treatment with oral proton pump inhibitors (PPIs) produces outcomes similar to those obtained with treatment with intravenous PPIs in patients with peptic ulcer bleeding.
Even when it's administered in a low-dose form that resists gastric acid and prevents tablet dissolution in the stomach, aspirin therapy causes peptic ulcer and increases the risk of 30-day mortality resulting from gastrointestinal (GI) disorder progression.
Though they conducted their analysis in China, four researchers have successfully demonstrated a link between babA2 gene and peptic ulcer disease (PUD) in Helicobacter pylori-infected populations within countries located on the Western Hemisphere.
Though it's common medical knowledge that an ulcer eating a hole through a patient's stomach requires immediate surgical treatment as a result of its life-threatening nature, new findings from a team of Danish researchers urge physicians to beat the clock in performing emergency surgery on perforated peptic ulcers (PPU).
After noticing the ample adverse effects of second-line Helicobacter pylori eradication treatments that utilize tetracycline, furazolidone and proton-pump inhibitors, one group of gastroenterologists set to work adding a probiotic compound to the regimen in an attempt to increase the stomach bacteria's eradication rate while curbing those unwanted effects.
Results from a mouse model study suggest that altering host gut microbiota via antibiotic treatment may reduce inflammation and other pathologies caused by H. pylori.
Researchers report that certain classes of comorbidities increase mortality risk in patients with peptic ulcer bleeding, but the presence of any comorbidities also affects mortality risk.
Expert advice from the 2013 AGA-ASGE Clinical Congress of Gastroenterology and Hepatology on managing diarrhea, constipation, abdominal pain, and other symptoms associated with irritable bowel syndrome (IBS).